Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in COVID-19

Clover Bio Starts Phase I Trial of Trimer-Tag COVID-19 Vaccine
Sinopharm Reports COVID-19 Vaccine Produced up to 100% Response in Phase I/II Trial
Sinovac Says COVID-19 Vaccine Offers Protection in 90% of Subjects
Sinopharm Reports Positive Preclinical Results for SARS-CoV-2 Vaccine
Alphamab and Institut Pasteur Shanghai to Develop COVID-19 mAb
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China